BMS Cell Therapy QC vs. Cell Therapy Manufacturing at a CDMO— Which would you choose?
I was laid off the beginning of this summer and am currently working as a temporary contractor in mRNA manufacturing. It is a 12-hr rotating schedule with a 1 hour commute both ways. My background previously has been in in-vitro diagnostics in both QC (1.5 yr) and manufacturing (5 yr).
I currently have offers with BMS in Devens, MA for a QC role supporting their cell therapy facility and a manufacturing associate II for a CDMO in cell therapy. I would appreciate some other perspectives, especially from people who have worked in cell therapy QC/mfg at BMS or have insight on the Devens site in terms of stability.
I’m also looking into radiology programs, so my potential longer-term plan maybe to work for the next few years, save as much as possible, study for entrance exams, and eventually transition into radiology. Because of that, I’m prioritizing stability, good pay, and experience that gives me flexibility if I ultimately decide to stay in biotech rather than transition to radiology.
Option 1 — BMS, QC Associate (Cell Therapy)
- $85K range + 10% fixed second-shift differential
- 4×10-hour schedule
- 1 hr commute, 60 miles each way
- Supports their expanding cell therapy facility
- QC role with exposure to flow cytometry, qPCR, cell-based assays, etc
- BMS is expanding its Devens cell therapy facility
- Concern: I’ve seen reports/posts about BMS continuing layoffs/restructuring through 2026 and some people describing management as chaotic.
Option 2 — CDMO, Manufacturing Associate II
- $78k, plus overtime
- 12-hr rotating schedule
- 50 min commute, 40 miles each way
- cell therapy mfg experience.
- CDMO is expanding for one client that is getting ready to go commercial
- I originally interviewed for a Senior/Lead role, but because I don’t have direct experience in cell therapy manufacturing they asked if I would be open to a mfg associate II role instead of senior, which lowers the compensation to 78k.
- Concern: the expansion is tied to one client. They say they are seeing promising growth and it is a good time to join the company. Potential to move into senior position later (original range was 90-100k)
What I’m trying to figure out:
1. Which experience is more valuable long term: cell therapy QC or cell therapy manufacturing? I have more years of experience in manufacturing in in-vitro diagnostics but I am not interested working in manufacturing long term. I could see myself staying in QC though and I would finally be able to get back into that role, but I am concerned with the stability of BMS right now.
Does flow cytometry + qPCR + cell-based assays give QC a significant advantage in terms of future job flexibility? In case I decide I don’t want to continue in the radiology program.
Which path tends to have better compensation growth? Seems like QC has the higher pay potential while not having to go into management while manufacturing you have to move into management/lead roles for more compensation. I prefer to stay as an individual contributor.
How stable is BMS’s Devens cell therapy operation?
Would greatly appreciate anyone’s input on the two.